Navigation Links
Oncolytics Biotech Inc. Announces 2008 First Quarter Results
Date:4/30/2008

$ $ $

-------------------------------------------------------------------------

Changes in:

Accounts receivable (5,014) 33,055 (85,099)

Prepaid expenses 98,822 (143,417) (161,478)

Accounts payable and accrued

liabilities (69,127) 232,940 2,752,100

-------------------------------------------------------------------------

Net change in non-cash working

capital 24,681 122,578 2,505,523

Portion related to investing

activities 23,078 (19,300) (22,543)

-------------------------------------------------------------------------

Net change associated with

operating activities 47,759 103,278 2,482,980

-------------------------------------------------------------------------

-------------------------------------------------------------------------

Other Non-Cash Items

Cumulative

from

Three Month Three Month inception

Period Period on April 2,

Ended Ended 1998 to

March 31, March 31, March 31,

2008 2007 2008

$ $ $

-------------------------------------------------------------------------

Foreign exchange loss - - 425,186

Donation of medical equipment - - 66,069

Loss on sale of Transition

<
'/>"/>
SOURCE Oncolytics Biotech Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related biology technology :

1. Oncolytics Biotech Inc. Announces Issuance of 23rd U.S. Patent
2. Oncolytics Biotech Inc. Reports Positive Interim Results of U.K. Phase Ia/Ib Combination REOLYSIN(R) and Radiation Clinical Trial
3. Media Advisory - Oncolytics Biotech Inc. to Present at BioPartnering Europe
4. Media Advisory - Oncolytics Biotech Inc. to Present at BIO InvestorForum 2007
5. Oncolytics Biotech Inc. Announces Approval for U.K. Clinical Trial Investigating REOLYSIN(R) in Combination with Cyclophosphamide
6. Oncolytics Biotech Inc. Collaborators to Present Positive Interim Results of U.K. Phase Ia/Ib Combination REOLYSIN(R) and Radiation Clinical Trial
7. Oncolytics Biotech Inc. Announces 2007 Third Quarter Results
8. Media Advisory - Oncolytics Biotech Inc. to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
9. Media Advisory - Oncolytics Biotech Inc. to Present at Toronto CFA Society
10. Oncolytics Biotech Inc. Announces Issuance of 24th U.S. Patent
11. Oncolytics Biotech Inc. to Present at Annual Vaccine Production Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... PALM BEACH, Fla. , July 11, 2014 /PRNewswire-iReach/ ... variety of high-quality peptides that are used solely in ... To honor two successful years in business, Maxim Peptide, ... LLC, has just launched a new and updated website ... the research blog section has been updated with fascinating ...
(Date:7/11/2014)... , Not for release, publication or ... any jurisdiction where to do so would constitute a violation ... plc ("Shire" or the "Company") (LSE: SHP, NASDAQ: ... it has held a meeting with representatives of AbbVie. ... prior agreement or approval of AbbVie. A further ...
(Date:7/11/2014)... -- Research and Markets  has announced the addition ... Industry Analysis, Size, Share, Growth, Trends and Forecast to ... http://photos.prnewswire.com/prnh/20130307/600769 Transfection is a ... RNA) into cells. This technology helps the cells to ... metabolism by affecting the nuclear genes. The transfection technology ...
(Date:7/11/2014)... Research ( http://www.bccresearch.com ) reveals in its new report, ... MARKETS , the global market for digital polymerase chain ... This is estimated to grow to $490 billion in ... of 28.6%. , New digital PCR technology has created ... broader PCR field. The opportunities presented by this technology ...
Breaking Biology Technology:Maxim Peptide Celebrates Second Anniversary Online with an Updated Website and Special Deals Section 2Shire plc - Statement re: Media Speculation 2International Transfection Technology Market - Industry Analysis, Size, Share, Growth, Trends and Forecast to 2019 2Global Market for Digital Polymerase Chain Reaction Technology to Reach $490 Billion by 2018; Equipment Sector Accounts for the Fastest Growing Segment With 33% CAGR 2Global Market for Digital Polymerase Chain Reaction Technology to Reach $490 Billion by 2018; Equipment Sector Accounts for the Fastest Growing Segment With 33% CAGR 3
... April 25, 2011 Perceptive Informatics , the ... PAREXEL International Corporation (NASDAQ: PRXL ), today ... recent webinar entitled "Implementing Bayesian Response Adaptive Trials." The ... was attended by over 300 professionals from the biopharmaceutical ...
... in the April 21st issue of Science magazine, ... report their findings that the ozone hole, which is located ... the Southern Hemisphere all the way to the equator. While ... the atmospheric flow in the high latitudes, the Columbia Engineering ...
... Collins Stewart LLC is pleased to announce the ... Beal Advisors and Liberty Tree Advisors. The purpose of ... and private equity transactions in the healthcare sector. Both ... healthcare advisory firms. Georgia Erbez – founder of Beal ...
Cached Biology Technology:Perceptive Informatics Global Survey Results Show Growing Industry Interest in Implementing Adaptive Trial Designs 2Perceptive Informatics Global Survey Results Show Growing Industry Interest in Implementing Adaptive Trial Designs 3Perceptive Informatics Global Survey Results Show Growing Industry Interest in Implementing Adaptive Trial Designs 4Perceptive Informatics Global Survey Results Show Growing Industry Interest in Implementing Adaptive Trial Designs 5Columbia engineering study links ozone hole to climate change all the way to the equator 2Columbia engineering study links ozone hole to climate change all the way to the equator 3Collins Stewart Announces Formation of Healthcare Investment Banking Alliance 2Collins Stewart Announces Formation of Healthcare Investment Banking Alliance 3
(Date:7/11/2014)... China Researchers from Salk Institute for Biological Studies, ... evaluated the safety and reliability of the existing ... new method, TALEN-HDAdV, which could significantly increased gene-correction ... This study published online in Cell Stell ... stem cell-based gene therapy. , The combination of ...
(Date:7/11/2014)... 2014 Researchers have pioneered a revolutionary new ... technology, called Virtual Finger, allows scientists to move ... and synapses using the flat surface of their ... imaging studies orders of magnitude more efficient, saving ... across many areas of experimental biology. The software ...
(Date:7/11/2014)... the normal circumstances, astrocytes participate in normal ... and exhibit therapeutic and repairing effects on ... have found that nerve cells differentiated from ... reduced viability, which produces influences on subsequent ... General Hospital, Hebei United University, China demonstrated ...
Breaking Biology News(10 mins):A new genome editing method brings the possibility of gene therapies closer to reality 2Virtual finger enables scientists to navigate and analyze complex 3D images 2
... Mass. -- In a study appearing this month in the ... that emissions from cars, trucks, planes and powerplants cause 13,000 ... The researchers analyzed data from 2005, the most recent year ... various sources of emissions in the country, car and truck ...
... of Minnesota has launched a startup that will provide ... harmful carbon dioxide emissions from fossil fuel combustion such ... LLC will use sequestered carbon dioxide rather than water ... thermal energy to generate electricity. The use of ...
... today at the International Liver Congress 2012 indicates the ... organ donors and surgical interventions) to be a highly ... tree stem/progenitor cells (BTSCs) have previously been identified in ... and been shown to generate in vitro and in ...
Cached Biology News:New study links air pollution and early death in the UK 2University of Minnesota startup offers game-changing energy solutions that reduce CO2 emissions 2University of Minnesota startup offers game-changing energy solutions that reduce CO2 emissions 3
... Includes gene gun unit, 5 O-rings, 5 barrel ... 9 V battery The Helios gene gun ... and direct gene transfer into a range of ... low-pressure helium pulse to sweep DNA- or RNA-coated ...
Mouse polyclonal antibody to PRDM2 - PR domain containing 2, with ZNF domain...
Intestinal Epithelium Differentiation Environment...
... Anti-phospho-Hck [pTyr 209/ pSer 211 ] affinity ... in Dulbecco's phosphate buffered saline (without Mg 2+ ... 1.0 mg/ml BSA (IgG and protease free) and ... from the region of mouse Hck that contains ...
Biology Products: